Browse COVID-19 resources from partners and CCSA experts – trusted sources for your information and research needs.

Canadian Centre on Substance Use and Addiction Evidence. Engagement. Impact.
Canadian Centre on Substance Use and Addiction

The information on COVID-19 and substance use in this section is organized under specific topics. Topics covered include harm reduction, opioids, alcohol, homeless and marginalized populations, and treatment services and recovery.

CCSA cannot vouch for the accuracy or currency of the information in these resources. Inclusion of a resource on this page does not imply endorsement or authorization by CCSA.

Alcohol

Alcohol

Resource Organization
Sociodemographic changes in emergency department visits due to alcohol during COVID-19 Drug and Alcohol Dependence
Alcohol and cannabis use during the pandemic: Canadian Perspectives Survey Series 6 Statistics Canada
Alcohol consumption and the COVID-19 pandemic : synthesizing knowledge for policy action Canadian Institutes of Health Research
Alcool, cannabis et tabac: les changements en matière de consommation d’alcool, de cannabis et de tabac durant la pandémie de COVID-19 (in French only) National Institute of Public Health in Quebec
Changes in alcohol consumption during the COVID-19 pandemic: exploring gender differences and the role of emotional distress Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice
COVID-19 impacts on drinking and mental health in emerging adults: Longitudinal changes and moderation by economic disruption and sex Alcoholism: Clinical and Experimental Research
Home delivery of legal intoxicants in the age of COVID‐19 Addiction
Pandémie et consommation de cannabis, de tabac et d’alcool (in French only) National Institute of Public Health in Quebec
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada International Journal of Drug Policy
A longitudinal study of change in substance use from before to during the COVID-19 pandemic in young adults The Lancet Regional Health - Americas
A longitudinal study of change in substance use from before to during the COVID-19 pandemic in young adults The Lancet Regional Health - Americas
A longitudinal study of change in substance use from before to during the COVID-19 pandemic in young adults The Lancet Regional Health - Americas
Alcohol and other substance use during the COVID-19 pandemic: A systematic review Drug and Alcohol Dependence
Use of alcohol and other drugs increased early in the COVID-19 pandemic EENet
Risky drinking during pandemic: Higher risk seen in women, those with financial and COVID-19 worries, older adults and high-income groups EENet
Research Snapshot: Changes in alcohol consumption during the COVID-19 pandemic in Canada EENet
Increases in Alcohol and Cannabis Use Associated with Deteriorating Mental Health among LGBTQ2+ Adults in the Context of COVID-19: A Repeated Cross-Sectional Study in Canada, 2020–2021 International Journal of Environmental Research and Public Health
Changes in Alcohol Consumption in Canada During the COVID-19 Pandemic: Associations With Anxiety and Self-Perception of Depression and Loneliness Alcohol and Alcoholism
Alcohol and substance use in pregnancy during the COVID-19 pandemic Drug Alcohol Dependence
Alcohol and cannabis use during the COVID-19 pandemic among transgender, gender-diverse, and cisgender adults in Canada BMC Public Health
A longitudinal approach to understanding risk factors for problem alcohol use during the COVID‐19 pandemic Alcoholism: Clinical and Experimental Research
Sociodemographic changes in emergency department visits due to alcohol during COVID-19 Drug and alcohol Dependance
Perceived Impact of COVID on Smoking, Vaping, Alcohol and Cannabis Use Among Youth and Youth Adults in Canada Canadian Journal of Psychiatry
Changes in Alcohol Consumption in Canada During the COVID-19 Pandemic: Associations With Anxiety and Self-Perception of Depression and Loneliness Alcohol and Alcoholism
Assessing international alcohol consumption patterns during isolation from the COVID-19 pandemic using an online survey: highlighting negative emotionality mechanisms BMJ Open
COVID-19-related social isolation stressors and their relationship to drinking behaviors in the general adult population The Dram
Effects of the COVID-19 pandemic and lockdown on alcohol use disorders and complications Addictive Disorders
Is another public health crisis brewing beneath the COVID-19 pandemic? Canadian Journal of Public Health
Home delivery of legal intoxicants in the age of COVID‐19 Addiction
Association of the COVID‐19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data Addiction
Changes in alcohol use as a function of psychological distress and social support following COVID-19 related University closings Addictive Behaviors
Drinking to cope with the pandemic: The unique associations of COVID-19-related perceived threat and psychological distress to drinking behaviors in American men and women Addictive Behaviors
Mental Wellness Moment — Making healthy choices about substance use (video) Alberta Health Services
Mental Wellness Moment — Alcohol and COVID-19 (video) Alberta Health Services
Alcohol use disorder: A pre-existing condition for COVID-19? Alcohol
Alcohol and COVID-19 Alcohol and Alcoholism
Are Patients With Alcohol Use Disorders at Increased Risk for Covid-19 Infection? Alcohol and Alcoholism
Complicated Alcohol Withdrawal—An Unintended Consequence of COVID-19 Lockdown Alcohol and Alcoholism
Coronavirus: top tips on alcohol and mental health  Alcohol Change UK
Tips for reducing your drinking in the home Alcohol Think Again
Options for meeting online Alcoholics Anonymous
Drinking to Cope During COVID‐19 Pandemic: The Role of External and Internal Factors in Coping Motive Pathways to Alcohol Use, Solitary Drinking, and Alcohol Problems Alcoholism: Clinical and Experimental Research
Supporting Access to Alcohol Use Disorder and Alcohol Withdrawal Treatment American Association of Addiction Medicine
High-Risk Drinking in Midlife Before Versus During the COVID-19 Crisis: Longitudinal Evidence From the United Kingdom American Journal of Preventive Medicine
Risk Mitigation in the Context of Dual Public Health Emergencies B.C. Centre on Substance Use
Statement: Prevention of Fetal Alcohol Spectrum Disorder (FASD) during the COVID-19 pandemic Canada FASD Research Network
Alcohol and the Immune System: 4 Things You Should Know (infographic) Canadian Centre on Substance Use and Addiction
Open versus Closed: The Risks Associated with Retail Liquor Stores during COVID-19 Canadian Centre on Substance Use and Addiction
COVID-19 and Increased Alcohol Consumption: NANOS Poll Summary Report Canadian Centre on Substance Use and Addiction
COVID-19, Alcohol and Cannabis Use (infographic) Canadian Centre on Substance Use and Addiction
COVID 19, Alcohol and Cannabis Use (report) Canadian Centre on Substance Use and Addiction
Alcohol, Pregnancy, and your Mental Health during COVID-19 Canadian FASD Research Network
Alcohol consumption in BC during COVID-19 Canadian Institute for Substance Use Research
Safer Drinking Tips During COVID-19 Canadian Institute for Substance Use Research
Alcohol consumption and the COVID-19 pandemic : synthesizing knowledge for policy action Canadian Institutes of Health Research
Alcohol Consumption and the COVID-19 Pandemic: Synthesizing Knowledge for Policy Action Canadian Institutes of Health Research
Telemedicine support for addiction services Canadian Research Initiative on Substance Misuse
Supporting people who use substances in shelter settings during the COVID‑19 pandemic Canadian Research Initiative on Substance Misuse
Giving the ok to ‘Stay In. Drink Up.’ What happens when the alcohol industry is in charge of alcohol marketing regulation during the COVID-19 pandemic Cancer Council Western Australia and Cancer Council Victoria
How do we cope? The impact of COVID-19 stress on drinking The DRAM
Describing the impact of the COVID‐19 pandemic on alcohol‐induced blackout tweets Drug and Alcohol Review
The burden of alcohol on health care during COVID‐19 Drug and Alcohol Review
Alcohol use in times of the COVID 19: Implications for monitoring and policy Drug and Alcohol Review
COVID‐19 makes a stronger research focus on home drinking more important than ever Drug and Alcohol Review
COVID ‐19 and alcohol in Australia: Industry changes and public health impacts Drug and Alcohol Review
Alcohol and Self-Isolation: What Are Quebecers Doing? Éduc'alcool
Isolation and alcohol during a pandemic Éduc'alcool
Alcohol Use: Risk Mitigation Strategies During a Pandemic First Nations Health Authority
Wellness Together Canada: Mental Health and Substance Use Support Government of Canada
Substance Use During the Pandemic Government of Newfoundland and Labrador
Alcohol consumption during the COVID-19 pandemic in the UK Institute of Alcohol Studies
Relationships between Perceived Stress, Depression and Alcohol Use Disorders in University Students during the COVID-19 Pandemic: A Socio-Economic Dimension International Journal of Environmental Research and Public Health
Alcohol Consumption during the COVID-19 Pandemic: A Cross-Sectional Survey of US Adults International Journal of Environmental Research and Public Health
Alcohol Withdrawal Rates in Hospitalized Patients During the COVID-19 Pandemic JAMA
Alcohol Withdrawal Rates in Hospitalized Patients During the COVID-19 Pandemic JAMA Network Open
Changes in Adult Alcohol Use and Consequences During the COVID-19 Pandemic in the US JAMA Network Open
Alcohol and COVID-19: How Do We Respond to This Growing Public Health Crisis? Journal of General Internal Medicine
Alcohol Policy and Coronavirus: An Open Research Agenda Journal of Studies on Alcohol and Drugs
Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? The Lancet
Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder The Lancet, Gastroenterology & Hepatology
MCA Alcohol and Covid Free Webinar Medical Council on Alcohol
Addressing excessive alcohol consumption during the COVID-19 pandemic Medical Express
Alcohol advertisers may be using social media to encourage parents to drink during COVID‐19 Medical Journal of Australia
Alcohol consumption in the COVID-19 era Minerva Gastroenterologica e Dietologica
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States Molecular Psychiatry
Rapid Review: What is the effect of the COVID-19 pandemic on alcohol use and alcohol-related harms? National Collaborating Centre for Methods and Tools
Clinical guide for the management of people with alcohol dependence during the coronavirus pandemic National Health Service, England
Combatting alcohol misuse among college students during the COVID-19 pandemic National Institute on Alcohol Abuse and Alcoholism
Helpful information on substance use during the COVID-19 pandemic Office of the Chief Medical Officer of Health, Government of New Brunswick
Alcohol dependence during COVID-19 lockdowns Psychiatry Research
COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol Public Health England and Department of Health and Social Care
People with a dependency a hidden cost of lockdown Royal Australian College of General Practitioners
Alcohol and the coronavirus pandemic: individual, societal and policy perspectives SFAM (Swedish Association of General Practice)
Substance Use & COVID-19: A Virtual Workshop for Service Providers! Skylark
There’s Life Beyond Addiction SMART Recovery
Alcohol and cannabis use during the pandemic: Canadian Perspectives Survey Series 6 Statistics Canada
Considerations for Crisis Centers and Clinicians in Managing the Treatment of Alcohol or Benzodiazepine Withdrawal during the COVID-19 Epidemic: March 19, 2020 Substance Abuse and Mental Health Services Administration
Managing Safe Alcohol Use During COVID-19 Thunderbird Partnership Foundation
More tips for managing Safe Alcohol Use during COVID-19 Thunderbird Partnership Foundation
Alcohol and Opioid use in the Time of COVID-19 (webinar summary and link) University of British Columbia
Day drinking during COVID-19 University of Queensland, Faculty of Medicine
Alcohol harm reduction is saving lives during COVID-19 UVic News (University of Victoria)
Support and resources for women Women For Sobriety
Alcohol and COVID-19: what you need to know World Health Organization, Europe
Du risque à la résilience : une approche axée sur l'équité concernant la COVID-19 (in French only) Agence de la santé publique du Canada
COVID-19 - Pandémie et consommation d’alcool (in French only) Institut national de santé publique du Québec

 

Harm Reduction

Harm Reduction

Resource Organization
A Descriptive Comparison of Substance Use Services in Recovery and Isolation Sites for People Experiencing Homelessness During the COVID-19 Pandemic, Boston and Toronto Public Health Reports
A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone Harm Reduction Journal
Going virtual: youth attitudes toward and experiences of virtual mental health and substance use services during the COVID-19 pandemic BMC Health Services Research
Overdose Prevention During a Pandemic Canadian Association of People who Use Drugs
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework International Journal of Drug Policy
Securing Safe Supply During COVID-19 and Beyond: Scoping Review and Knowledge Mobilization Canadian Institutes of Health Research
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada International Journal of Drug Policy
Research Snapshot: The negative impacts of COVID-19 on people who use drugs in Canada Evidence Exchange Network
Positive Tests for Fentanyl, Heroin, Opioids Climb During Pandemic Addiction Professional
Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program AIDS and Behavior
COVID-19 Webinars Addictions Foundation of Manitoba
Mental Wellness Moment — Making healthy choices about substance use (video) Alberta Health Services
Mental Wellness Moment — Managing cravings during COVID-19 (video) Alberta Health Services
Mental Wellness Moment — Alcohol and COVID-19 (video) Alberta Health Services
Mental Wellness Moment — Cannabis safety during COVID-19 (video) Alberta Health Services
COVID-19 — Supporting Access to Buprenorphine American Society of Addiction Medicine
COVID-19: Harm Reduction and Overdose Response  B.C. Centre for Disease Control
People who use substances  B.C. Centre for Disease Control
Substance Use and COVID-19 B.C. Centre on Substance Use
Risk Mitigation in the Context of Dual Public Health Emergencies B.C. Centre on Substance Use
COVID-19: Responding to Opioid Overdoses in Overdose Prevention Services (OPS) and Supervised Consumption Sites (SCS) BC Ministry of Health
Strengthening Recovery During Crises: A four-part webinar series discussing addiction recovery amid public health crises British Columbia Centre on Substance Use
Supporting Harm Reduction in COVID 19 Shelter and Self Isolation (webinar) Canadian Alliance to End Homelessness
Virtual Care for Mental Health and Substance Use During COVID-19 [infographic] Canadian Centre on Substance Use and Addiction, Canadian Psychological Association, Canadian Society of Addiction Medicine, Mental Health Commission of Canada, The Royal
Coping with Stress, Anxiety, and Substance Use During Covid-19: How Animals Can Help [infographic] Canadian Centre on Substance Use and Addiction
Methamphetamine, the Respiratory System and COVID-19 [report] Canadian Centre on Substance Use and Addiction
Methamphetamine, Cocaine and COVID-19 Health Risks [infographic] Canadian Centre on Substance Use and Addiction
COVID-19 and Cannabis Smoking and Vaping: Four Things You Should Know [report] Canadian Centre on Substance Use and Addiction
COVID-19 and Cannabis Smoking: 4 Things You Should Know [infographic] Canadian Centre on Substance Use and Addiction
COVID-19 and Cannabis: How to Reduce Your Risk [infographic] Canadian Centre on Substance Use and Addiction
Securing Safe Supply During COVID-19 and Beyond: Scoping Review and Knowledge Mobilization Canadian Institutes of Health Research
Rapid Review of the Impacts of “Big Events” On People Who Use Drugs and Delivery of Harm Reduction and Drug Treatment Services: Implications for Strengthening Systems in Response to COVID-19 Canadian Institutes of Health Research
Securing Safe Supply During COVID-19 and Beyond: Scoping Review and Knowledge Mobilization Canadian Institutes of Health Research
Don't forget our dual public health crises Canadian Journal of Emergency Medicine
Supporting people who use substances in acute care settings during the COVID-19 pandemic Canadian Research Initiative on Substance Misuse
Medications and other clinical approaches to support physical distancing for people who use substances during the COVID-19 pandemic Canadian Research Initiative on Substance Misuse
Strategies to Reduce SARS-CoV-2 Transmission in Supportive Recovery Programs and Residential Addiction Treatment Services Canadian Research Initiative on Substance Misuse
Harm reduction worker safety during the COVID-19 global pandemic Canadian Research Initiative on Substance Misuse
Telemedicine support for addiction services Canadian Research Initiative on Substance Misuse
Supporting people who use substances in shelter settings during the COVID‑19 pandemic Canadian Research Initiative on Substance Misuse
Mental Health and the COVID Pandemic  Centre for Addiction and Mental Health (CAMH)
Coronavirus – General Hygiene Harm Reduction Tips Crew
COVID-19 Safer Drug Use Harm Reduction Tips Eastern Health / Opioid Dependance Treatment Centre of Excellence
The impact of heroin illicit market in the framework of COVID 19 pandemic (Letter to the Editor) European Review for Medical and Pharmacological Sciences
How the Pandemic Hit People Who Use Drugs, in Their Own Words Filter
Substance Use – Harm Reduction and COVID-19 First Nations Health Authority
COVID-19 Safer Drug Use Harm Reduction Tips Government of Newfoundland and Labrador
Syringe Services and Harm Reduction Provider Operations During the COVID-19 Outbreak Harm Reduction Coalition
COVID-19 Guidance for People Who Use Drugs and Harm Reduction Programs  Harm Reduction Coalition
COVID-19, Prisons and Drug Policy Harm Reduction International
Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID‑19 response Harm Reduction Journal
COVID-19 Crisis: Harm Reduction Resources for People who Use Drugs  INPUD (International Network of People who Use Drugs)
COVID-19 Survey Report 1: Health & Rights of People who Use Drugs in a COVID-19 Environment INPUD (International Network of People who Use Drugs)
Coronavirus disease (COVID-19): Resources and information International Drug Policy Consortium (IDPC)
Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19 International Journal of Drug Policy
An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom International Journal of Drug Policy
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19 International Journal of Drug Policy
Addiction psychiatry and COVID-19: impact on patients and service provision Irish Journal of Psychological Medicine
COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings Journal of Substance Abuse Treatment
Integrating harm reduction and clinical care: Lessons from Covid-19 respite and recuperation facilities Journal of Substance Abuse Treatment
COVID-19 Harm Reduction COVID-19: Stay Home, Stay Safe New Zealand Drug Foundation
Helpful information on substance use during the COVID-19 pandemic Office of the Chief Medical Officer of Health, Government of New Brunswick
Avoiding a new epidemic during a pandemic: The importance of assessing the risk of substance use disorders in the COVID-19 era Psychiatry Research
Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services Public Health
COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol Public Health England and Department of Health and Social Care
COVID19: Opioid Risk Mitigation Research-to-Policy Collaboration
COVID-19, Stimulant Use, and Harm Reduction Resolve to Save Lives and Vital Strategies
Harm reduction during COVID-19 Thunderbird Partnership Foundation
'A Pandemic Upon an Epidemic.' Syringe Services Struggle to Provide Care to Those Battling Drug Addiction Amid COVID-19 Time
COVID-19 Harm Reduction Tips  Toronto Public Health
Coronavirus and Drug Harm Reduction Transform
COVID-19 HIV Prevention, Treatment, Care and Support for People Who Use Drugs and People in Prison   United Nations Office on Drugs and Crime
Pandemic Response Planning Checklist for Homeless & Housing Services Providers  Vancouver Coastal Health
Vancouver CAT prescriber guidelines webinar Vancouver Coastal Health
Prescriber Guidelines for Risk Mitigation in the Context of Dual Public Health Emergencies Vancouver Coastal Health
Safer Use Strategies to Reduce Risk of COVID-19 Transmission   Vancouver Costal Health
Coronavirus (COVID-19): guidance for substance misuse and homelessness services (version 1) Welsh Government
Harm Reduction Guidance  Yale Program in Addiction Medicine
Guidance for People Who Use Substances on COVID-19   Yale Program in Addiction Medicine, Global Health Justice Partnership, and Crackdown
Gambling and Gaming During COVID-19: Prevalence, Implications and Strategies to Stay Safe YMCA of Greater Toronto
A Message for Young People Who Use Drugs Youth Rise
Pour un usage de substances à moindre risque dans le cadre de la pandémie de COVID-19 (in French only) Association des intervenants en dépendance du Québec
COVID-19: Qu’est-ce que la réduction des méfaits? (in French only) CQDT

 

Homeless/Marginalized Populations

Homeless/Marginalized Populations

Resource Organization
The influence of sex, gender, age, and ethnicity on psychosocial factors and substance use throughout phases of the COVID-19 pandemic PLOS ONE
Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder Journal of Substance Abuse Treatment
Risk factors for elevations in substance use and consequences during the COVID-19 pandemic among sexual and gender minorities assigned female at birth Drug and Alcohol Dependence
Virtual Substance Use & Psychiatry Service BC First Nations Health Authority
Strengthening Recovery During Crises: A four-part webinar series discussing addiction recovery amid public health crises British Columbia Centre on Substance Use
Supporting Harm Reduction in COVID 19 Shelter and Self Isolation (webinar) Canadian Alliance to End Homelessness
Telemedicine support for addiction services Canadian Research Initiative on Substance Misuse
Supporting people who use substances in shelter settings during the COVID‑19 pandemic Canadian Research Initiative on Substance Misuse
A glass half empty or a glass half full? Addressing the opioid crisis through the lens of COVID-19 Drug and Alcohol Dependence
Evaluating the impact of COVID-19: A cohort comparison study of drug use and risky sexual behavior among sexual minority men in the U.S.A. Drug and Alcohol Dependence
Guidance for providers of services for people experiencing homelessness (in the context of COVID-19)  Government of Canada
Youth Homelessness: Mental Health and Substance Use Patterns During COVID-19 Homeless Hub
Overdose Safety and Support During the Coronavirus Outbreak Homeless Services Association of B.C.
COVID-19 printable materials, sector resources and webinar recordings Homelessness Services Association of BC
Coronavirus disease (COVID-19): Resources and information International Drug Policy Consortium (IDPC)
The perfect storm: COVID-19, mass incarceration and the opioid epidemic International Journal of Drug Policy
Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report Journal of Addiction Medicine
COVID‐19 During the Opioid Epidemic – Exacerbation of Stigma and Vulnerabilities Journal of Rural Health
Sheltering in place and social distancing when the services provided are housing and social support: The COVID-19 health crisis and recovery housing Journal of Substance Abuse Treatment
Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic Journal of Substance Abuse Treatment
Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada Journal of Substance Abuse Treatment
COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings Journal of Substance Abuse Treatment
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States Molecular Psychiatry
Pandemic Response Planning Checklist for Homeless & Housing Services Providers  Vancouver Coastal Health
Coronavirus (COVID-19): guidance for substance misuse and homelessness services (version 1) Welsh Government
WHO Interim Guidance on Preparedness, prevention and control of COVID-19 in prisons and other places of detention (2020)  World Health Organization

 

Opioids

Opioids

Resource Organization
Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model Addiction Science & Clinical Practice
Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada JAMA Network Open
A rapid review of opioid substitution therapy during major disruptions to medical care Canadian Institutes of Health Research
Review of opioid risk assessment tools with the growing need for telemedicine Pain Management
A glass half empty or a glass half full? Addressing the opioid crisis through the lens of COVID-19 Drug and Alcohol Dependence
Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies BMC Public Health
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study Substance Abuse Treatment, Prevention, and Policy
The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review Substance Abuse Treatment, Prevention, and Policy
Wastewater analysis suggests that consumption of fentanyl, cannabis and methamphetamine increased in the early pandemic period Statistics Canada, The Daily
COVID-19 and opioid use disorder: Expanding treatment access in rural settings Nursing 2021
Patterns of Medication and Healthcare Use among People who Died of an Opioid-Related Toxicity during the COVID-19 Pandemic in Ontario Ontario Drug Policy Research Network
Opioid treatment programs, telemedicine and COVID-19: A scoping review Substance Abuse
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis International Journal of Drug Policy
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy Ontario Drug Policy Research Network
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing International Journal of Drug Policy
Clinical and demographic differences in the willingness to use self-administered at-home COVID-19 testing measures among persons with opioid use disorder Substance Abuse
Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder Journal of Substance Abuse Treatment
The Impact of the COVID-19 Pandemic on Opioid-Related Harm in Ontario Science Briefs of the Ontario COVID-19 Science Advisory Table
Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program AIDS and Behavior
Unintended consequences of the transition to telehealth for pregnancies complicated by opioid use disorder during the coronavirus disease 2019 pandemic American Journal of Obstetrics and Gynecology
COVID-19 - Supporting Access to Buprenorphine American Society of Addiction Medicine
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis Annals of Internal Medicine
Collision of the COVID-19 and Addiction Epidemics Annals of Internal Medicine
People who use substances  B.C. Centre for Disease Control
COVID-19: Information for Opioid Agonist Treatment Prescribers and Pharmacists  B.C. Centre on Substance Use
Substance Use and COVID-19 B.C. Centre on Substance Use
Risk Mitigation in the Context of Dual Public Health Emergencies B.C. Centre on Substance Use
A Rapid Review of Opioid Substitution Therapy During Major Disruptions to Medical Care Canadian Institutes of Health Research
A rapid review of opioid substitution therapy during major disruptions to medical care Canadian Institutes of Health Research
Don't forget our dual public health crises Canadian Journal of Emergency Medicine
Telemedicine support for addiction services Canadian Research Initiative on Substance Misuse
Supporting people who use substances in shelter settings during the COVID‑19 pandemic Canadian Research Initiative on Substance Misuse
COVID-19 - Opioid Agonist Treatment Guidance  Canadian Society of Addiction Medicine
Opioid Use Disorder in the age of Covid-19  Canadian Society of Addiction Medicine
COVID -19: Opioid Agonist Treatment Guidance Centre for Addiction and Mental Health
Coronavirus – General Hygiene Harm Reduction Tips Crew
Socially-supportive norms and mutual aid of people who use opioids: An analysis of Reddit during the initial COVID-19 pandemic Drug and Alcohol Dependance
Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder Drug and Alcohol Dependence
Signal of increased opioid overdose during COVID-19 from emergency medical services data Drug and Alcohol Dependence
Caring for Pregnant and Parenting Women with OUD During the COVID-19 Pandemic (slides from webinar) Foundation for Opioid Response Efforts
Substance Use During the Pandemic Government of Newfoundland and Labrador
Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic JAMA Internal Medicine
COVID‐19 During the Opioid Epidemic – Exacerbation of Stigma and Vulnerabilities Journal of Rural Health
A Primary Care Response to COVID‐19 for Patients with an Opioid Use Disorder Journal of Rural Health
Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic Journal of Substance Abuse Treatment
Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19 Journal of Substance Abuse Treatment
COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings Journal of Substance Abuse Treatment
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States Molecular Psychiatry
Rapid Review: What is the effect of the COVID-19 pandemic on opioid and substance use and related harms? National Collaborating Centre for Methods and Tools
Helpful information on substance use during the COVID-19 pandemic Office of the Chief Medical Officer of Health, Government of New Brunswick
COVID-19 and Opioid Treatment Programs Ohio Mental Health and Addiction Services
Preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic Ontario Drug Policy Research Network
COVID19 pandemic and people with opioid use disorder: innovation to reduce risk Psychiatry Research
COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol Public Health England and Department of Health and Social Care
COVID19: Opioid Risk Mitigation Research-to-Policy Collaboration
Substance Use & COVID-19: A Virtual Workshop for Service Providers! Skylark
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study Substance Abuse Treatment, Prevention, and Policy
A double-edged sword of using opioids and COVID-19: a toxicological view Substance Abuse Treatment, Prevention, and Policy
Managing Withdrawal during COVID-19 Thunderbird Partnership Foundation
Alcohol and Opioid use in the Time of COVID-19 (webinar summary and link) University of British Columbia
Research Guidelines in Response to Covid-19 (March 30, 2020)  University of the Fraser Valley
VCH Overdose Response in Overdose Prevention Sites and Supervised Consumption Sites for COVID-19 Vancouver Coastal Health
Vancouver CAT prescriber guidelines webinar Vancouver Coastal Health
How COVID Has Worsened the Opioid Epidemic Yale Insights
Harm Reduction Guidance  Yale Program in Addiction Medicine
A Message for Young People Who Use Drugs Youth Rise
Du risque à la résilience : une approche axée sur l'équité concernant la COVID-19 (in French only) Agence de la santé publique du Canada
Le traitement du trouble lié à l’utilisation d’opioïdes (TUO) (in French only) Collège des médecins du Québec

 

Treatment and Recovery

Treatment and Recovery

Resource Organization
Adapting inpatient addiction medicine consult services during the COVID-19 pandemic Addiction Science & Clinical Practice
A rapid review of opioid substitution therapy during major disruptions to medical care Canadian Institutes of Health Research
A Descriptive Comparison of Substance Use Services in Recovery and Isolation Sites for People Experiencing Homelessness During the COVID-19 Pandemic, Boston and Toronto Public Health Reports
A rapid review of opioid substitution therapy during major disruptions to medical care Canadian Institutes of Health Research
Adapting inpatient addiction medicine consult services during the COVID-19 pandemic Addiction Science & Clinical Practice
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada International Journal of Drug Policy
Going virtual: youth attitudes toward and experiences of virtual mental health and substance use services during the COVID-19 pandemic BMC Health Services Research
Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada JAMA Network Open
Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies BMC Public Health
Screening and brief intervention for substance use disorders in times of COVID-19: potential opportunities, adaptations, and challenges American Journal of Drug and Alcohol Abuse
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study Substance Abuse Treatment, Prevention, and Policy
Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic Journal of Substance Abuse Treatment
COVID-19 and opioid use disorder: Expanding treatment access in rural settings Nursing 2021
Strategies Adopted by Addiction Facilities during the Coronavirus Pandemic to Support Treatment for Individuals in Recovery or Struggling with a Substance Use Disorder: A Scoping Review International Journal of Environmental Research and Public Health
Opioid treatment programs, telemedicine and COVID-19: A scoping review Substance Abuse
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis International Journal of Drug Policy
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy Ontario Drug Policy Research Network
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing International Journal of Drug Policy
A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic Drug and Alcohol Dependance
Review of the adaptations in opioid agonist treatment during the COVID-19 pandemic: Focus on buprenorphine-based treatment Journal of Opioid Management
Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada JAMA Network Open
Adapting Substance Use Treatment for HIV Affected Communities During COVID-19: Comparisons Between a Sexually Transmitted Infections (STI) Clinic and a Local Community Based Organization AIDS and Behavior
Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program AIDS and Behavior
Drinking to Cope During COVID‐19 Pandemic: The Role of External and Internal Factors in Coping Motive Pathways to Alcohol Use, Solitary Drinking, and Alcohol Problems Alcoholism: Clinical and Experimental Research
Screening and brief intervention for substance use disorders in times of COVID-19: potential opportunities, adaptations, and challenges American Journal of Drug and Alcohol Abuse 
COVID-19 — Supporting Access to Buprenorphine American Society of Addiction Medicine
Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel Anaesthesia
COVID-19 pandemic and addiction: Current problems and future concerns Asian Journal of Psychiatry
People who use substances  B.C. Centre for Disease Control
Risk Mitigation in the Context of Dual Public Health Emergencies B.C. Centre on Substance Use
Virtual Substance Use & Psychiatry Service BC First Nations Health Authority
Starting Buprenorphine Outside of Hospitals/Clinics California Bridge
Impacts of the COVID-19 Pandemic on Substance Use Treatment Capacity in Canada Canadian Centre on Substance Use and Addiction
Virtual Care for Mental Health and Substance Use During COVID-19 [infographic] Canadian Centre on Substance Use and Addiction, Canadian Psychological Association, Canadian Society of Addiction Medicine, Mental Health Commission of Canada, The Royal
A rapid review of opioid substitution therapy during major disruptions to medical care Canadian Institutes of Health Research
A rapid review of opioid substitution therapy during major disruptions to medical care Canadian Institutes of Health Research
Digital Health Solutions to Support Women with Addiction During COVID-19: Applying a Gender- and Trauma-Informed Lens Canadian Institutes of Health Research
Rapid Evidence and Gap Map of Virtual Care Solutions for Youth and Families to Mitigate the Impact of the COVID-19 Pandemic on Pain, Mental Health and Substance Use Canadian Institutes of Health Research
Supporting people who use substances in acute care settings during the COVID-19 pandemic Canadian Research Initiative on Substance Misuse
Medications and other clinical approaches to support physical distancing for people who use substances during the COVID-19 pandemic Canadian Research Initiative on Substance Misuse
Strategies to Reduce SARS-CoV-2 Transmission in Supportive Recovery Programs and Residential Addiction Treatment Services Canadian Research Initiative on Substance Misuse
Harm reduction worker safety during the COVID-19 global pandemic Canadian Research Initiative on Substance Misuse
Telemedicine support for addiction services Canadian Research Initiative on Substance Misuse
Supporting people who use substances in shelter settings during the COVID‑19 pandemic Canadian Research Initiative on Substance Misuse
COVID-19 - Opioid Agonist Treatment Guidance  Canadian Society of Addiction Medicine
COVID -19: Opioid Agonist Treatment Guidance Centre for Addiction and Mental Health
CAMH: Mental Health and the COVID-19 Pandemic Centre for Addiction and Mental Health (CAMH)
Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder Drug and Alcohol Dependence
Alcohol use in times of the COVID 19: Implications for monitoring and policy Drug and Alcohol Review
COVID-19 and Substance Use Disorders: There Will Be Silver Linings Families for Addiction Recovery
Substance Use Disorders and COVID-19: Multi-Faceted Problems Which Require Multi-Pronged Solutions Frontiers in Psychiatry
A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report Harm Reduction Journal
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic Harm Reduction Journal
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19 International Journal of Drug Policy
Addiction psychiatry and COVID-19: impact on patients and service provision Irish Journal of Psychological Medicine
Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic JAMA Internal Medicine
Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019: Recommendations to Enhance Adoption JAMA Psychiatry
Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report Journal of Addiction Medicine
Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA Journal of Addiction Medicine
COVID-19 vulnerability among people who use drugs: recommendations for global public health programmes and policies Journal of the International AIDS Society
Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic Journal of Substance Abuse Treatment
Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19 Journal of Substance Abuse Treatment
Sheltering in place and social distancing when the services provided are housing and social support: The COVID-19 health crisis and recovery housing Journal of Substance Abuse Treatment
Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond Journal of Substance Abuse Treatment
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade? Journal of Substance Abuse Treatment
Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care? Journal of Substance Abuse Treatment
Impacts of COVID-19 on residential treatment programs for substance use disorder Journal of Substance Abuse Treatment
COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings Journal of Substance Abuse Treatment
COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns Journal of Substance Abuse Treatment
Youth OUD treatment during and after COVID: Increasing family involvement across the services continuum Journal of Substance Abuse Treatment
Mobile van delivery of extended-release buprenorphine and extended-release naltrexone for youth with OUD: An adaptation to the COVID-19 emergency Journal of Substance Abuse Treatment
Providing addiction services during a pandemic: Lessons learned from COVID-19 Journal of Substance Abuse Treatment
Revising our attitudes towards agonist medications and their diversion in a time of pandemic Journal of Substance Abuse Treatment
Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada Journal of Substance Abuse Treatment
A delicate compromise: Striking a balance between public safety measures and the psychosocial needs of staff and clients in residential substance use disorder treatment amid COVID-19 Journal of Substance Abuse Treatment
The use of mindfulness dialogue for life in substance use disorder treatment in the time of COVID-19 Journal of Substance Abuse Treatment
“I have to be around people that are doing what I'm doing”: The importance of expanding the peer recovery coach role in treatment of opioid use disorder in the face of COVID-19 health disparities Journal of Substance Abuse Treatment
Telehealth sustains patient engagement in OUD treatment during COVID-19 Journal of Substance Abuse Treatment
Is necessity also the mother of implementation? COVID-19 and the implementation of evidence-based treatments for opioid use disorders Journal of Substance Abuse Treatment
With crisis comes opportunity: Unanticipated benefits resulting from pivots to take-home naloxone (THN) programs during the COVID-19 pandemic Journal of Substance Abuse Treatment
Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook Mayo Clinic Proceedings
You can start drug addiction treatment over the phone—and thanks to COVID, more people are starting to Medical Express
COVID-19 Harm Reduction COVID-19: Stay Home, Stay Safe New Zealand Drug Foundation
Managing Addiction Recovery in Isolation Online Master of Social Work Programs
What the Pandemic Teaches Us About the Need for MAT Psychology Today
Rapid Access to Consultative Expertise  RACE Rapid Access to Consultative Expertise
Leveraging video telehealth for the transitional pain service in response to COVID-19 Regional Anesthesia and Pain Medicine
Updated guidance for contingency planning for services during COVID-19 published  Scottish Drugs Forum
There’s Life Beyond Addiction SMART Recovery
COVID-19 guide for drug and alcohol residential rehab and detox services Social Care Institute for Excellence
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study Substance Abuse Treatment, Prevention, and Policy
Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic Substance Abuse
Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemic United Nations Office on Drugs and Crime
Prescriber Guidelines for Risk Mitigation in the Context of Dual Public Health Emergencies Vancouver Coastal Health
Support and resources for women Women For Sobriety
Le traitement du trouble lié à l’utilisation d’opioïdes (TUO) (in French only) Collège des médecins du Québec
La pharmacothérapie de remplacement des substances psychoactives dans le contexte de pandémie de COVID-19 au Québec: Guide clinique à l’intention des prescripteurs (in French only) Institut universitaire sur les dépendances (IUD) du CIUSSS du Centre-Sud-de-l’Île-de-Montréal

Pain

Pain

Resource Organization
Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel Anaesthesia
COVID-19: Information Resources Canadian Arthritis Patient Alliance
Rapid Evidence and Gap Map of Virtual Care Solutions for Youth and Families to Mitigate the Impact of the COVID-19 Pandemic on Pain, Mental Health and Substance Use Canadian Institutes of Health Research
EMCDDA trendspotter briefing - Impact of COVID-19 on drug services and help-seeking in Europe European Monitoring Centre for Drugs and Drug Addiction
Resources for Canadians living with pain during COVID-19 Government of Canada
COVID-19 news and resources for people living with pain Pain BC
Managing patients with chronic pain during the COVID-19 outbreak considerations for the rapid introduction of remotely supported (e-health) pain management services PAIN: The Journal of the International Association for the Study of Pain
Review of opioid risk assessment tools with the growing need for telemedicine Pain Management
Impact of the COVID-19 pandemic on the pharmacological, physical, and psychological treatments of pain: findings from the Chronic Pain & COVID-19 Pan-Canadian Study Pain Reports
Leveraging video telehealth for the transitional pain service in response to COVID-19 Regional Anesthesia and Pain Medicine

 

Cannabis

Cannabis

Resource Organization
Alcool, cannabis et tabac: les changements en matière de consommation d’alcool, de cannabis et de tabac durant la pandémie de COVID-19 (in French only) National Institute of Public Health in Quebec
Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization Biological Psychiatry Global Open Science
Alcohol and cannabis use during the pandemic: Canadian Perspectives Survey Series 6 Statistics Canada
Home delivery of legal intoxicants in the age of COVID‐19 Addiction
Pandémie et consommation de cannabis, de tabac et d’alcool (in French only) National Institute of Public Health in Quebec
Wastewater analysis suggests that consumption of fentanyl, cannabis and methamphetamine increased in the early pandemic period Statistics Canada, The Daily
A longitudinal study of change in substance use from before to during the COVID-19 pandemic in young adults The Lancet Regional Health - Americas
Getting high to cope with COVID-19: Modelling the associations between cannabis demand, coping motives, and cannabis use and problems Addictive Behaviors
Increases in Alcohol and Cannabis Use Associated with Deteriorating Mental Health among LGBTQ2+ Adults in the Context of COVID-19: A Repeated Cross-Sectional Study in Canada, 2020–2021 International Journal of Environmental Research and Public Health
Alcohol and cannabis use during the COVID-19 pandemic among transgender, gender-diverse, and cisgender adults in Canada BMC Public Health

 

Gambling

Gambling

Resource Organization
Online Gambling in the Midst of COVID-19: A Nexus of Mental Health Concerns, Substance Use and Financial Stress International Journal of Mental Health and Addiction

We use cookies to ensure that we give you the best experience possible on our website. 

You can change your cookie settings in your web browser at any time. If you continue without changing your settings, we’ll assume that you are happy to receive cookies from our website. Review our Privacy Notice for more information.